A Form 4 filed with the SEC on September 22, 2026 discloses that Juan R. Luciano, a director of Eli Lilly & Co (NYSE:LLY), acquired 13.6637 shares of common stock on September 21, 2026 under the company's Directors' Deferral Plan.

Key Highlights

  • Reporting person: Juan R. Luciano, listed as a Director of Eli Lilly & Co.
  • Transaction date: September 21, 2026, with the filing dated September 22, 2026.
  • Shares acquired: 13.6637 shares of common stock, coded as an acquisition (A).
  • Price per share: $1,164.89, as stated in the filing.
  • Beneficial ownership following transaction: 16,956.8138 shares held directly.
  • Deferral election: Shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan, to be settled in common stock following separation from service.

Juan Luciano's Deferred Share Acquisition Under Lilly Directors' Deferral Plan

According to the Form 4 filing, Juan R. Luciano, a director at Eli Lilly & Co (NYSE:LLY), acquired 13.6637 shares of the company's common stock on September 21, 2026 at a price of $1,164.89 per share. The transaction is recorded with an acquisition code (A) in Table I, covering non-derivative securities. The filing was signed by Christopher Anderson on behalf of Juan R. Luciano pursuant to an authorization on file.

The filing includes an explanatory footnote stating: "At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service." Following this transaction, Luciano's directly held beneficial ownership stands at 16,956.8138 shares, as reported in the filing.

No derivative securities transactions were reported in Table II of the filing. The filing was made by one reporting person and does not indicate any amendment to a prior Form 4.

What Was Disclosed

The filing reports a single acquisition of 13.6637 shares of Eli Lilly common stock by director Juan R. Luciano at $1,164.89 per share on September 21, 2026, deferred as stock units under the Lilly Directors' Deferral Plan, bringing his direct beneficial ownership to 16,956.8138 shares.